The cause and risk factors of Alzheimer's disease (AD) are largely unknown. Studies on possible radiation-induced AD-like pathogenesis and behavioral consequences are important because humans are exposed to ionizing radiation (IR) from various sources. It was reported that totalbody irradiations (TBI) at 10 cGy of low linear energy transfer (LET) X-rays to mice triggered acute transcriptional alterations in genes associated with cognitive dysfunctions. However, it was unknown whether low doses of IR could induce AD-like changes late after exposure. We reported previously that 10 cGy X-rays induced early transcriptional response of several AD-related genes in hippocampi without late AD-like pathogenesis and memory impairment in mice. Here, further studies on two low doses (5 or 10 cGy) of high LET carbonion irradiations are reported. On expression of 84 AD-related genes in hippocampi, at 4 hr after TBI, 5 cGy induced a significant upregulation of three genes (Abca1, Casp3, and Chat) and 10 cGy led to a marked upregulation of one gene (Chat) and a downregulation of three genes (Apoe, Ctsd, and Il1a), and, at 1 year after TBI, one gene (Il1a) was significantly downregulated in 10 cGy-irradiated animals. Changes in spatial learning ability and memory and induction of AD-like pathogenesis were not detected by in vivo brain imaging for amyloid-b peptide accumulation and by immunohistochemical staining of amyloid precursor protein, amyloid-b protein, tau, and phosphorylated tau protein.These findings indicate that low doses of carbon-ion irradiations did not cause behavioral impairment or AD-like pathological change in mice. V C 2014Key words: carbon-ion irradiation; hippocampi; gene expression; behavioral impairment; Alzheimer's diseaselike pathogenesis Alzheimer's disease (AD) is the most common etiology for dementia. It is characterized by formation of both senile plaques containing amyloid-b peptide (Ab) derived from amyloid precursor protein (APP) and neurofibrillary tangles containing hyperphosphorylated tau protein (p-tau) in the brain. AD is the leading cause of dementia among the elderly and the fourth leading cause of death (Wang et al., 2007). It is currently estimated that 35 million people are suffering from AD or AD-related dementia all over the world, and the global prevalence of AD is to increase to 80 million by 2040, and to more than 115 million by 2050 (Hampel et al., 2011; Alzheimer's Disease International website, 2013). Thus, it is absolutely crucial that we understand better the pathogenesis of AD as part of a prevention strategy.The causes of and risk factors for AD remain largely unknown except for certain inherited forms of the disease. AD probably develops as a result of multiple factors.